Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
Mycophenolic acid (MPA), the active drug moiety of mycophenolate, is a potent immunosuppressant agent, which is increasingly being used in the treatment of patients with various autoimmune diseases. An understanding of the pharmacokinetics and pharmacodynamics of mycophenolate in this population sho...
| Main Authors: | Abd. Rahman, Nurul Azrin, Tett, Susan E., Staatz, Christian E. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer International Publishing AG
2013
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/30553/ http://irep.iium.edu.my/30553/ http://irep.iium.edu.my/30553/ http://irep.iium.edu.my/30553/1/Azrin_AbdRahman_2013.pdf |
Similar Items
-
How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?
by: Abd. Rahman, Nurul Azrin, et al.
Published: (2014) -
Applying pharmacokinetic/pharmacodynamic
principles in critically ill patients: optimizing
efficacy and reducing resistance development
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2015) -
Pharmacokinetic/pharmacodynamics-optimized antimicrobial therapy in patients with hospital-acquired pneumonia/ventilator-associated pneumonia
by: Sulaiman, Helmi, et al.
Published: (2017) -
Plasma & subcutaneous tissue pharmacokinetics of piperacillin in a large cohort of critically ill patients with sepsis
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2014) -
Pharmacokinetic and sub-chronic toxicity study of a fixed dose combination and a sustained release tablet
by: Chatterjee, Bappaditya, et al.
Published: (2017)